Company intelligence / Profile preview

PeploBio

Milton Keynes, England, United Kingdompeplobio.co.uk ↗

Ownership: Private
Development stage: Commercial

Overview

PeploBio is an ISO 15189-accredited clinical contract research organization specializing in advanced testing, immune monitoring, regulatory consulting, genomics, proteomics, biospecimen procurement, and diagnostic solutions. It played a significant role during the COVID-19 pandemic as one of the UK's top private labs. The company has since expanded to offer comprehensive support for IVD/medical device manufacturers and biopharma clients—including assay development/validation and management of exploratory through phase 2 clinical trials. In 2024 it partnered with IncellDX to launch the first Long COVID diagnostic test in the UK/EU using incellKINE technology.

Modalities: Diagnostic testGenomicsFlow cytometry assaysImmunoassays
Industry: Contract Research Organization

Partnerships

IncellDX

Beyond the preview

Go deeper on PeploBio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PeploBio.

Explore the full profile